Google
DXCM 株価分析 — Dexcom Inc (Healthcare >> Medical Devices)
DXCM に関するよくある質問
DXCMのPER（株価収益率）は？
Dexcom Inc（DXCM）は現在PER 28.77倍で取引されています。
DXCMのROE（自己資本利益率）は？
Dexcom IncのROEは38.14%です。
DXCMの配当利回りは？
Dexcom Incの配当利回りは0.00%です。
DXCMの品質スコア（Quality Score）は？
当社のAIはDXCMの総合財務品質を100点中92点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。
DXCMは今が買い時ですか？
当社AIのタイミングスコアは100点中91点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。
DXCMはどのセクターに属しますか？
Dexcom IncはHealthcare >> Medical Devicesセクターに分類されます（NASDAQ市場）
DXCM AI Analysis Summary
Our AI summary for DXCM: Dexcom Inc (NASDAQ), Healthcare >> Medical Devices sector. The stock currently trades at a P/E of 28.77, ROE of 38.14%, a dividend yield of 0.00%. Its financial Quality Score stands at 92/100 — fundamentals stronger than most of the market. The AI Timing Score is 91/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 83.45
Price
8.91
(11.95%)
Day Change
|
|
|---|
DXCM, ファンダメンタルスコアはexcellent ( ファンダメンタル = 92) そして テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- OUTPERFORM
- Signal Description
- Company financial health is Good
- Reason
-
ROAがROEに比べて低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are ok , financial health is not quite good , and ability to make profit is good , ...
| Deepscope 分析 |
|
60% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 89 |
| Magic Formula Rank by ROA |
1048
|
| Magic Formula Rank by ROE |
1048
|
| Magic Formula Rank by ROIC |
948
|
| Price | 83.45 |
| PBV / Sector |
10.97 / -101.57
|
| Earning Per Share | 2.90 |
| PE / Sector |
28.77 / 31.23
|
| PEG or PE/Growth / Sector |
0.74 / 0.40
|
| Average 1M Daily Value |
353.49 M
GREAT
|
| Average 1W Daily Value |
489.72 M
GREAT
|
| Timing Factors |
|
71% |
| Financial Health |
|
52% |
| ポイントになる統計 |
|
72% |
| 配当 |
|
4% |
| 登録情報 |
| Analyze Date | 2026-08-01 07:59:45 |
| Symbol | DXCM |
| Name | DEXCOM INC |
| Sector | Healthcare >> Medical Devices |
| Market | NASDAQ |
| Listed Shares | 385.87 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 28,762.97 / 20,104.97 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 6340 Sequence Drive, San Diego, CA, United States, 92121
Phone: 858 200 0200
Website: https://www.dexcom.com
Employees: 11,000
Sector: Healthcare >> Medical Devices
Description: DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 Day, an integrated continuous glucose monitoring system; Dexcom G6, a CGM system; Dexcom ONE+ to replace fingerstick blood glucose testing for diabetes treatment decisions; Stelo, a biosensor designed for adults with prediabetes and Type 2 diabetes who do not use insulin; Dexcom Share, a remote monitoring system; and Dexcom Follow application. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.
Analyst Ratings & Target Price
ME vs SECTOR Healthcare >> Medical Devices
Click a bubble to view stock details · Bubble size represents market capitalization share
